en
Scientific article
Editorial
English

Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?

Published inExpert review of neurotherapeutics, vol. 22, no. 4, p. 283-286
Publication date2022-04
First online date2022-03-28
Keywords
  • Aducanumab
  • Alzheimer’s disease
  • COVID-19 vaccines
  • Amyloid-related imaging abnormalities
  • Cerebral hemorrhage
  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized / adverse effects
  • COVID-19
  • COVID-19 Vaccines / adverse effects
  • Cerebral Hemorrhage / chemically induced
  • Humans
Affiliation Not a UNIGE publication
Citation (ISO format)
MOHANASUNDARAM, ArunSundar et al. Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk? In: Expert review of neurotherapeutics, 2022, vol. 22, n° 4, p. 283–286. doi: 10.1080/14737175.2022.2053112
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1473-7175
18views
1downloads

Technical informations

Creation04/28/2023 12:26:45 PM
First validation10/02/2023 2:51:14 PM
Update time10/02/2023 2:51:14 PM
Status update10/02/2023 2:51:14 PM
Last indexation02/01/2024 10:44:58 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack